1 Shiley Center for Orthopaedic Research and Education at Scripps Health , La Jolla, California.
Tissue Eng Part A. 2014 Feb;20(3-4):683-92. doi: 10.1089/ten.TEA.2012.0751. Epub 2013 Oct 19.
Chondrocytes have been generated in vitro from a range of progenitor cell types and by a number of strategies. However, achieving reconstitution of actual physiologically relevant, appropriately-laminated cartilage in situ that would be applicable to conditions, such as arthritis and cartilage degeneration remains elusive. This lack of success is multifactorial and includes limited cell source, decreased proliferation rate of mature chondrocytes, lack of maintenance of phenotype, reduced matrix synthesis, and poor integration with host tissue. We report an efficient approach for deriving mesenchymal chondroprogenitor cells from human embryonic stem cells. These cells generated tissue containing cartilage-specific matrix proteins that integrated in situ in a partial-thickness defect in ex vivo articular cartilage harvested from human arthritic joints. Given that stem cells provide a virtually inexhaustible supply of starting material and that our technique is easily scalable, cartilaginous tissue primed and grafted in this manner could be suitable for clinical translation.
软骨细胞已经从多种祖细胞类型和多种策略中在体外生成。然而,要实现在体内重建实际的生理相关的、适当分层的软骨,适用于关节炎和软骨退化等情况,仍然难以实现。这种失败是多方面的,包括有限的细胞来源、成熟软骨细胞增殖率降低、表型维持的缺乏、基质合成减少以及与宿主组织的不良整合。我们报告了一种从人类胚胎干细胞中获得间充质软骨祖细胞的有效方法。这些细胞生成的组织含有软骨特异性基质蛋白,这些蛋白在从人类关节炎关节中收获的关节软骨的部分厚度缺陷中原位整合。鉴于干细胞提供了几乎用之不竭的起始材料供应,并且我们的技术易于扩展,以这种方式制备和移植的软骨组织可能适合临床转化。